Dapsone and Aprepitant drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dapsone (dapsone) and Aprepitant (aprepitant). Common drug interactions include fatigue among females and dizziness among males.
The phase IV clinical study analyzes what interactions people have when they take Dapsone and Aprepitant. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Dapsone?
Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.
What is Aprepitant?
Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.
13 people who take Dapsone and Aprepitant together, and have interactions are studied.

What are the common drug interactions of Dapsone and Aprepitant, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Visual impairment
male:
- Dizziness
- Fluid imbalance (imbalance of fluid in body in intake and fluid lost)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Septic shock (shock due to blood infection)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Enterobacter sepsis (sepsis due to bacteria of the family enterobacteriaceae)
- Enterococcal sepsis
- Febrile neutropenia (fever with reduced white blood cells)
- Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
What are the common drug interactions of Dapsone and Aprepitant, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
- Klebsiella infection
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Septic shock (shock due to blood infection)
- Febrile neutropenia (fever with reduced white blood cells)
- Hypotension (abnormally low blood pressure)
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Enterobacter sepsis (sepsis due to bacteria of the family enterobacteriaceae)
- Enterococcal sepsis
- Hypotension (abnormally low blood pressure)
- Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
60+:
- Nausea (feeling of having an urge to vomit)
- Dizziness
- Fluid imbalance (imbalance of fluid in body in intake and fluid lost)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Hypovolaemia (a decreased volume of circulating blood in the body)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Vomiting
- Fatigue (feeling of tiredness)
- Visual impairment
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 5 people, 38.46%
- Haematopoietic Stem Cell Mobilisation: 5 people, 38.46%
- Blood Sodium Decreased: 4 people, 30.77%
- White Blood Cell Count Increased: 2 people, 15.38%
- Stress And Anxiety: 2 people, 15.38%
- Nausea And Vomiting: 2 people, 15.38%
- Nausea (feeling of having an urge to vomit): 2 people, 15.38%
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 15.38%
- White Blood Cell Count Decreased: 1 person, 7.69%
- Pain: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Dapsone and Aprepitant?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Dapsone (11,732 reports)
- Aprepitant (6,992 reports)
Browse all drug interactions of Dapsone and Aprepitant:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dapsone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aprepitant:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dapsone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aprepitant and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on dapsone and aprepitant (the active ingredients of Dapsone and Aprepitant, respectively), and Dapsone and Aprepitant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Donepezil Hydrochloride and Sofosbuvir - 54 seconds ago
- Could Oncaspar cause Diabetes? - a minute ago
- Stress And Anxiety and Hypovitaminosis - a minute ago
- Drug interactions of Prednisone and Tegretol - 2 minutes ago
- Drug interactions of Algin and Clonazepam - 3 minutes ago
- Could Norco cause Skin - Clammy? - 4 minutes ago
- Drug interactions of Spironolactone and Cod Liver Oil - 4 minutes ago
- Could Fludara cause Clonus? - 4 minutes ago
- Drug interactions of Bactrim and Vitamin B9 - 6 minutes ago
- Drug interactions of Ciprofloxacin Hydrochloride and Ketoprofen - 6 minutes ago